Midi Health vs Trava

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Midi Health vs Trava: Overview

Choosing between Midi Health and Trava for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.

Midi Health offers both semaglutide and tirzepatide at $164/month with a rating of 8.6/10. Trava also provides both semaglutide and tirzepatide at $118/month with a 7.2/10 rating.

With only a $46/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$46/mo
Rating Difference
1.4
Winner
Midi Health
Best For
Quality

Midi Health

View full Midi Health review →
Rating
8.6/10Better
Monthly Price
$164
Medications
compounded GLP-1compounded GLP-1/GIPbrand-name GLP-1s

Pros

  • The GLP-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked July 28, 2026)
  • Compounded GLP-1 injectable runs $165.90 for the lowest doses, $270.90 in the mid range and $355.00 at the top; the dual-action GLP-1/GIP injectable runs $210.00 to $434.00, all for a 4-week supply
  • Sublingual options are offered as well, from $164.00 for GLP-1 and $209.00 for dual-action GLP-1/GIP, for people who will not inject
  • Its partner compounding pharmacies are 503B-accredited. 503B outsourcing facilities register with the FDA, are subject to current good manufacturing practice requirements and are FDA-inspected - a materially higher standard than the 503A pharmacies most competitors use
  • There is no membership fee. You pay for care and medication only
  • Visits are insurance-covered for qualifying patients, and HSA/FSA funds can be used for copays and services
  • Midi will also prescribe brand-name GLP-1s sent to a pharmacy of your choice, so you are not locked into compounded product if you would rather have the approved drug
  • The efficacy claim is the best-sourced in this category. Midi reports patients lost an average of 16 lbs after six or more months, and footnotes it to a retrospective analysis of 6,958 patients who completed two or more weight management visits between 1 May 2025 and 30 April 2026, while stating plainly that weight data were self-reported and results are not guaranteed
  • Care is genuinely whole-person for midlife women - perimenopause, menopause, weight, mood and memory, sexual wellness, hair and skin, sleep, and cancer survivorship - with lab orders and lifestyle support included where appropriate
  • Available in all 50 states

Cons

  • The compounded products are still not FDA-approved. 503B accreditation raises the manufacturing standard considerably but does not mean the FDA has reviewed these preparations for safety or efficacy
  • Midi never names the active drug anywhere in its pricing. Everything is labelled 'GLP-1' or 'GLP-1/GIP'. The dose ladders shown - 0.25 through 2.5 mg, and 2.5 through 15 mg - match the standard semaglutide and tirzepatide titrations exactly, but you should confirm with the clinician what you are actually being prescribed
  • Microdosing is offered from $34 a week for eligible patients. Microdosing is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses, and the 16 lb outcome figure covers patients on 'a range of treatments', not microdosing specifically
  • Medicaid and Medi-Cal patients cannot be treated at all, even if they offer to pay cash
  • Medicare does not cover Midi, and beneficiaries cannot submit claims for visits, medications or associated services
  • Prices rise steeply as you titrate up. Injectable GLP-1 more than doubles from $165.90 to $355.00, and the dual-action sublingual runs from $209.00 to $460.00, so the entry price is not what you will pay long term
  • The 16 lb average comes from self-reported weights in a retrospective chart review with no control group - well documented, but not a controlled trial
  • GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Pancreatitis and gallbladder disease are recognised risks
Choose Midi Health

Trava

View full Trava review →
Rating
7.2/10
Monthly Price
$118Cheaper
Medications
semaglutidetirzepatidemetformin

Pros

  • One of the cheapest published entry prices in the category: "GLP-1's As Low as $118"
  • Both a GLP-1 with B12 and a GLP-1 + GIP with B12 injectable are offered, so semaglutide-class and tirzepatide-class options are both available
  • A free assessment before you pay anything
  • It is explicit that medication only follows a real consultation: "Before receiving any medication, patients are required to complete an online assessment and have a consultation with one of our healthcare providers"
  • Metformin is offered from $69.98, which is a legitimate lower-cost option for some patients rather than an upsell
  • A wider catalogue including B-12, lipotropic injections and peptides for people who want them
  • Prices for every product line are published on the collection pages rather than gated behind signup

Cons

  • The medication is compounded and not FDA-approved
  • "Tested in FDA approved labs" is a phrase that does not mean anything specific. The FDA does not approve labs in this sense, and the claim implies a regulatory blessing the product does not have
  • "As low as $118" is a floor price with no dose ladder published, so it is unclear what happens to the price as you titrate
  • Adding B12 to a compounded GLP-1 is a common way to make a product "personalised" enough to justify compounding it. There is no evidence B12 improves weight-loss outcomes
  • No phone number, support email or business address is published
  • No refund, cancellation, HSA/FSA or insurance information is published
  • No pharmacy is named
  • No states-served list
Choose Trava

Feature-by-feature comparison

FeatureMidi HealthTrava
Monthly Price$164$118
Rating8.6/107.2/10
Medicationscompounded GLP-1, compounded GLP-1/GIP, brand-name GLP-1ssemaglutide, tirzepatide, metformin
Insurance AcceptedYesNo
Support HoursNot publishedNot published
Live ChatNoNo
Free ShippingYesNo
Shipping SpeedDiscreet shipping included in every quoted medication priceNot published
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up FrequencyContinued care visits with the same clinician, covered by insurance for qualifying patientsNot published
Money-back GuaranteeNone publishedNone published
Cancellation PolicyNo membership fee and no subscription lock-in; you pay for care and medication onlyNot published

Which should you choose?

Choose Midi Health if you:

  • Prefer a higher-rated service (8.6/10 vs 7.2/10)
  • Need insurance coverage for your treatment
  • Value: the glp-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked july 28, 2026)

Choose Trava if you:

  • Want to save $46/month with a more affordable option
  • Value: one of the cheapest published entry prices in the category: "glp-1's as low as $118"

Website previews

Midi Health

Midi Health website

Trava

Trava website

Our recommendation

Midi Health comes out ahead with a higher rating of 8.6/10. It also provides multiple medication options including both semaglutide and tirzepatide.
Get started with Midi Health

Compare other providers

Compare GLP-1 Brands